Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Nitrendipine, also known as Baypress, is a second-generation dihydropyridine calcium channel blocker. It is a vasodilating, dihydropyridine calcium antagonist that is more selective for vascular smooth muscle than for myocardial tissue, making it an effective vasodilator. Nitrendipine is used in the treatment of mild-to-moderate essential hypertension and has a prolonged therapeutic effect compared to other calcium channel blockers like nifedipine.

39562-70-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 39562-70-4 Structure
  • Basic information

    1. Product Name: Nitrendipine
    2. Synonyms: NITRENDIPINE;1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylicacidethy;baye5009;bayotensin;baypress;ethylmethyl1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxy;lmethylester;nidrel
    3. CAS NO:39562-70-4
    4. Molecular Formula: C18H20N2O6
    5. Molecular Weight: 360.36
    6. EINECS: 254-513-1
    7. Product Categories: Pharmaceutical;Intermediates & Fine Chemicals;Pharmaceuticals;Calcium channel;Ion Channels;API;Pharmaceutical intermediate;Pharmaceutical intermediates
    8. Mol File: 39562-70-4.mol
  • Chemical Properties

    1. Melting Point: 1580C
    2. Boiling Point: 492.4°C (rough estimate)
    3. Flash Point: 249.5 °C
    4. Appearance: yellow to green/powder
    5. Density: 1.3595 (rough estimate)
    6. Vapor Pressure: 8.08E-09mmHg at 25°C
    7. Refractive Index: 1.5700 (estimate)
    8. Storage Temp.: Store at RT
    9. Solubility: methanol: 15 mg/mL
    10. PKA: 2.79±0.70(Predicted)
    11. Water Solubility: Soluble in DMSO (17.5 mg/ml), methanol (15 mg/ml), ethyl acetate, and ethanol (25 mM). Insoluble in water.
    12. Stability: Stable for 1 year from date of purchase as supplied. Protect from light. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 week.
    13. CAS DataBase Reference: Nitrendipine(CAS DataBase Reference)
    14. NIST Chemistry Reference: Nitrendipine(39562-70-4)
    15. EPA Substance Registry System: Nitrendipine(39562-70-4)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 20/21/22
    3. Safety Statements: 36
    4. WGK Germany: 1
    5. RTECS: US5653000
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 39562-70-4(Hazardous Substances Data)

39562-70-4 Usage

Uses

Used in Cardiovascular Applications:
Nitrendipine is used as an antihypertensive agent for the treatment of primary (essential) hypertension to decrease blood pressure. It functions as a calcium channel blocker, which helps in managing blood pressure and reducing the workload on the heart.
Used in Neurological Applications:
Nitrendipine modulates NMDA receptor channel function in mammalian neurons, which can be beneficial in treating certain neurological conditions.
Used in Vascular Applications:
Nitrendipine has been shown to inhibit neutrophil adhesion to vascular endothelium, which can help in preventing inflammation and other vascular issues.
Used in Combination Therapy:
Nitrendipine is used alone or with an angiotensin-converting enzyme inhibitor to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina, providing a comprehensive approach to managing these conditions.
Chemical Properties:
Nitrendipine is a crystalline solid with the chemical formula 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid methyl ethylester.
Brand Names:
Baypress (Bayer) and BAYOTENSIN are the brand names under which Nitrendipine is marketed.

Originator

Bayer (W. Germany)

Biochem/physiol Actions

Ca2+ channel blocker; anti-hypertensive.

References

1) Meyer et al., (1981), (Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions); Arzneimittelforschung 31 407 2) Stoepel et al., (1981), Pharmacological studies of the antihypertensive effect of nitrendipine; Arzneimittelforschung 31 2056

Check Digit Verification of cas no

The CAS Registry Mumber 39562-70-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,5,6 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 39562-70:
(7*3)+(6*9)+(5*5)+(4*6)+(3*2)+(2*7)+(1*0)=144
144 % 10 = 4
So 39562-70-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H20N2O6/c1-5-26-18(22)15-11(3)19-10(2)14(17(21)25-4)16(15)12-7-6-8-13(9-12)20(23)24/h6-9,15-16H,5H2,1-4H3/t15?,16-/m1/s1

39562-70-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (N0905000)  Nitrendipine  European Pharmacopoeia (EP) Reference Standard

  • 39562-70-4

  • N0905000

  • 1,880.19CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001456)  Nitrendipine for peak identification  European Pharmacopoeia (EP) Reference Standard

  • 39562-70-4

  • Y0001456

  • 1,880.19CNY

  • Detail
  • Sigma

  • (N144)  Nitrendipine  >95%, powder

  • 39562-70-4

  • N144-25MG

  • 792.09CNY

  • Detail
  • Sigma

  • (N144)  Nitrendipine  >95%, powder

  • 39562-70-4

  • N144-100MG

  • 2,607.93CNY

  • Detail
  • Sigma

  • (N144)  Nitrendipine  >95%, powder

  • 39562-70-4

  • N144-500MG

  • 9,389.25CNY

  • Detail

39562-70-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name nitrendipine

1.2 Other means of identification

Product number -
Other names 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:39562-70-4 SDS

39562-70-4Synthetic route

ethyl acetoacetate
141-97-9

ethyl acetoacetate

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

methyl 3-aminocrotonate
14205-39-1

methyl 3-aminocrotonate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With sodium tosylate In water for 0.4h; Reagent/catalyst; Time; Hantzsch Dihydropyridine Synthesis; Microwave irradiation; Reflux; Green chemistry;94%
With C21H38N(1+)*Mo11O40PV(4-)*3H(1+) In ethanol at 78℃; for 8h; Catalytic behavior; Hantzsch Pyridine Synthesis; Green chemistry;78%
Hantzsch Dihydropyridine Synthesis; Darkness; Reflux;59%
Benzyl-{2-[5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-ethyl}-dimethyl-ammonium; iodide

Benzyl-{2-[5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-ethyl}-dimethyl-ammonium; iodide

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 25℃;92%
(S)-1,1-Dibenzyl-3-[(R)-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-piperidinium; bromide

(S)-1,1-Dibenzyl-3-[(R)-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-piperidinium; bromide

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 25℃; for 24h;92%
Multi-step reaction with 3 steps
1: 67 percent / KOH / tetrahydrofuran / 24 h / 25 °C
2: 93 percent / acetone / Heating
3: 92 percent / KOH / ethanol / 25 °C
View Scheme
methanol
67-56-1

methanol

C23H27N4O6(1+)*F6P(1-)

C23H27N4O6(1+)*F6P(1-)

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With sodium methylate for 16h; Reflux;92%
(S)-1-Benzyl-3-[(R)-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-1-methyl-piperidinium; iodide

(S)-1-Benzyl-3-[(R)-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-1-methyl-piperidinium; iodide

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 25℃;91%
Multi-step reaction with 3 steps
1: 32 percent / KOH / tetrahydrofuran / 25 °C
2: 93 percent / acetone / Heating
3: 92 percent / KOH / ethanol / 25 °C
View Scheme
ethyl aminocrotonate

ethyl aminocrotonate

methyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate
119128-13-1

methyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
In isopropyl alcohol for 10h; Heating / reflux;89%
methyl 2-(3-nitrophenylmethylene)acetoacetate
39562-17-9

methyl 2-(3-nitrophenylmethylene)acetoacetate

ethyl aminocrotonate
626-34-6, 7318-00-5, 41867-20-3

ethyl aminocrotonate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
In ethanol for 6h; Reflux;86%
at 90℃; for 0.15h; Microwave irradiation;
methyl 3-aminocrotonate
21731-17-9

methyl 3-aminocrotonate

ethyl 2-[(3-Nitrophenyl)methylene]-3-oxobutanoate
39562-16-8

ethyl 2-[(3-Nitrophenyl)methylene]-3-oxobutanoate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Stage #1: methyl 3-aminocrotonate; ethyl 2-[(3-Nitrophenyl)methylene]-3-oxobutanoate In ethanol at 75 - 80℃; for 1h;
Stage #2: With acetic anhydride In ethanol at 75 - 80℃; for 1h; Solvent;
86%
(S)-1-Allyl-1-benzyl-3-[(R)-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-piperidinium; bromide

(S)-1-Allyl-1-benzyl-3-[(R)-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carbonyloxy]-piperidinium; bromide

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 25℃;85%
Multi-step reaction with 3 steps
1: 26 percent / KOH / tetrahydrofuran / 25 °C
2: 93 percent / acetone / Heating
3: 92 percent / KOH / ethanol / 25 °C
View Scheme
ethyl 2-(3-nitrophenylmethylene)-3-oxobutanoate
39562-16-8

ethyl 2-(3-nitrophenylmethylene)-3-oxobutanoate

methyl 3-aminocrotonate
14205-39-1

methyl 3-aminocrotonate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Stage #1: ethyl 2-(3-nitrophenylmethylene)-3-oxobutanoate; methyl 3-aminocrotonate In ethanol at 70 - 75℃; for 1h;
Stage #2: With hydrogenchloride In ethanol; water at 70 - 75℃;
80%
In ethanol for 8h; Heating;79%
With acetic acid; N-ethyl-N,N-diisopropylamine In ethanol Reflux;
ethyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate
39562-16-8

ethyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate

1,1,1-Triphenyl-3-methyl-4-(methoxycarbonyl)-2-aza-1λ5-phosphabuta-1,3-diene
81777-30-2

1,1,1-Triphenyl-3-methyl-4-(methoxycarbonyl)-2-aza-1λ5-phosphabuta-1,3-diene

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
In chloroform at 25℃; for 0.5h;77%
ethyl acetoacetate
141-97-9

ethyl acetoacetate

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

methyl (E)-3-aminocrotonate
14205-39-1

methyl (E)-3-aminocrotonate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With sodium butylmonoglycolsulphate In water for 0.0833333h; Heating; Irradiation; microwave irradiation;72%
3'-nitrobenzylideneacetoacetic acid ethyl ester
70076-42-5

3'-nitrobenzylideneacetoacetic acid ethyl ester

methyl 3-aminocrotonate
21731-17-9

methyl 3-aminocrotonate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
In ethanol67%
ethyl acetoacetate
141-97-9

ethyl acetoacetate

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With aluminum oxide; ammonia In methanol Hantzsch pyridine synthesis; Heating;50%
With pyridine; 4 A molecular sieve; polysterene-based acid-cleavable Rink amine resin; trifluoroacetic acid 1) CH2Cl2, rt, 3 d; 2) 45 deg C, 24 h; 3) CH2Cl2, 45 min;; Yield given. Multistep reaction;
methyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate
119128-13-1

methyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate

ethyl acetoacetate
141-97-9

ethyl acetoacetate

A

m-nifedipine
21881-77-6

m-nifedipine

B

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester
21829-28-7

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester

C

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With ammonium hydroxide In ethanol for 24h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
ethyl acetoacetate
141-97-9

ethyl acetoacetate

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

methyl (E)-3-aminocrotonate
14205-39-1

methyl (E)-3-aminocrotonate

A

m-nifedipine
21881-77-6

m-nifedipine

B

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester
21829-28-7

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester

C

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
In ethanol for 10h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

ethyl (E)-3-aminobut-2-enoate
41867-20-3

ethyl (E)-3-aminobut-2-enoate

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

A

m-nifedipine
21881-77-6

m-nifedipine

B

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester
21829-28-7

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester

C

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
In ethanol for 10h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
ethyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate
39562-16-8

ethyl (Z)-2-(3-nitrobenzylidene)-3-oxobutanoate

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

A

m-nifedipine
21881-77-6

m-nifedipine

B

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester
21829-28-7

2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester

C

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With ammonium hydroxide In ethanol for 24h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
Nicardipine
55985-32-5

Nicardipine

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 93 percent / acetone / Heating
2: 92 percent / KOH / ethanol / 25 °C
View Scheme
(R)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-((S)-1-benzyl-piperidin-3-yl) ester 5-methyl ester

(R)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-((S)-1-benzyl-piperidin-3-yl) ester 5-methyl ester

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 93 percent / CHCl3 / Heating
2: 67 percent / KOH / tetrahydrofuran / 24 h / 25 °C
3: 93 percent / acetone / Heating
4: 92 percent / KOH / ethanol / 25 °C
View Scheme
Multi-step reaction with 2 steps
1: 93 percent / CHCl3 / Heating
2: 92 percent / KOH / ethanol / 24 h / 25 °C
View Scheme
Multi-step reaction with 4 steps
1: 95 percent / CHCl3 / Heating
2: 26 percent / KOH / tetrahydrofuran / 25 °C
3: 93 percent / acetone / Heating
4: 92 percent / KOH / ethanol / 25 °C
View Scheme
3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: gaseous HCl / toluene / 40 h / Ambient temperature
2: 79 percent / ethanol / 8 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: piperidine; acetic acid / 30 °C / Neat (no solvent)
2: ethanol / 6 h / Reflux
View Scheme
acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

n-C7H15Br or n-C7H15I

n-C7H15Br or n-C7H15I

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: gaseous NH3, p-toluenesulfonic acid / toluene / Heating
2: 79 percent / ethanol / 8 h / Heating
View Scheme
(+)-2-methylthiomethyl-6-methyl-5-carbomethoxy-3-carboethoxy-4-(3-nitrophenyl)-1,4-dihydropyridine
131767-68-5, 131796-79-7

(+)-2-methylthiomethyl-6-methyl-5-carbomethoxy-3-carboethoxy-4-(3-nitrophenyl)-1,4-dihydropyridine

methyl iodide
74-88-4

methyl iodide

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With sodium borohydrid In N,N-dimethyl-formamide
methyl (S)-3-[(2-methoxy-methylpyrrolidin-1-yl)-imino]-butyrate

methyl (S)-3-[(2-methoxy-methylpyrrolidin-1-yl)-imino]-butyrate

2,3-dimethyl-2,3-diaminobutane
20485-44-3

2,3-dimethyl-2,3-diaminobutane

ethyl 2-[(3-Nitrophenyl)methylene]-3-oxobutanoate
39562-16-8

ethyl 2-[(3-Nitrophenyl)methylene]-3-oxobutanoate

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
With n-butyllithium; ammonium chloride In tetrahydrofuran; methanol; hexane; dichloromethane
acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: piperidine; acetic acid / 30 °C / Neat (no solvent)
2: ethanol / 6 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: ammonia / ethanol / 4 h / 2 - 20 °C
2: acetic acid; N-ethyl-N,N-diisopropylamine / ethanol / Reflux
View Scheme
3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: alumina / neat (no solvent) / 120 °C / Microwave irradiation; Green chemistry
2: 0.15 h / 90 °C / Microwave irradiation
View Scheme
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

(+/-)-Oxidized Nitrendipine
89267-41-4

(+/-)-Oxidized Nitrendipine

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate In water; acetone for 0.166667h; Ambient temperature;100%
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; iron(III) chloride hexahydrate; oxygen; sodium nitrite In acetic acid; acetonitrile at 20℃; for 0.75h;97%
With lead(IV) acetate In dichloromethane; acetic acid at 20℃; for 1.25h;96%
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

methyl iodide
74-88-4

methyl iodide

N-methylnitrendipine
50698-12-9

N-methylnitrendipine

Conditions
ConditionsYield
95%
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

phenylboronic acid
98-80-6

phenylboronic acid

3-ethyl 5-methyl 2,6-dimethyl-4-(3-(phenylsulfonamido)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate

3-ethyl 5-methyl 2,6-dimethyl-4-(3-(phenylsulfonamido)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate

Conditions
ConditionsYield
With potassium pyrosulfite; tetrabutyl-ammonium chloride; potassium carbonate In acetonitrile at 130℃; for 24h; Sealed tube;61%
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

N-nitroso-nitrendipine

N-nitroso-nitrendipine

Conditions
ConditionsYield
With hydrogenchloride; sodium nitrite In water at 37℃; for 6h; pH=3 - 3.5;44%
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

allyl bromide
106-95-6

allyl bromide

1-allyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester

1-allyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester

Conditions
ConditionsYield
22%
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

propargyl bromide
106-96-7

propargyl bromide

MRS 1845

MRS 1845

Conditions
ConditionsYield
22%
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

ethyl iodide
75-03-6

ethyl iodide

1-ethyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester

1-ethyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester

Conditions
ConditionsYield
21%
benzyl chloride
100-44-7

benzyl chloride

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

1-benzyl-2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl ester 5-ethyl ester

1-benzyl-2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-methyl ester 5-ethyl ester

Conditions
ConditionsYield
16%
1H-imidazole
288-32-4

1H-imidazole

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

1,4-dihydro-2,6-bis(1H-imidazol-1-ylmethyl)-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid ethyl methyl diester
123754-04-1

1,4-dihydro-2,6-bis(1H-imidazol-1-ylmethyl)-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid ethyl methyl diester

Conditions
ConditionsYield
With phenyltrimethylammonium tribromide 1.) MeCN, below 10 deg C, 0.75 h, 2.) below 30 deg C, 2 h; Yield given. Multistep reaction;
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

A

SL 5721
64603-72-1

SL 5721

B

5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid
74936-72-4

5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid

C

methyl 2-methyl-4-(3-nitrophenyl)-5-oxo-5,7-dihydro-furo<3,4-b>pyridine-3-carboxylate
64603-74-3

methyl 2-methyl-4-(3-nitrophenyl)-5-oxo-5,7-dihydro-furo<3,4-b>pyridine-3-carboxylate

D

ethyl-2-methyl-4-(3-nitrophenyl)-5-oxo-5,7-dihydrofuro<3,4-b>3-pyridinecarboxylate
89288-25-5

ethyl-2-methyl-4-(3-nitrophenyl)-5-oxo-5,7-dihydrofuro<3,4-b>3-pyridinecarboxylate

E

(R)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-((2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxy-tetrahydro-pyran-2-yl) ester 5-methyl ester
138135-46-3

(R)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-((2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxy-tetrahydro-pyran-2-yl) ester 5-methyl ester

F

(S)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-((2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxy-tetrahydro-pyran-2-yl) ester 5-methyl ester
138135-45-2

(S)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-((2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxy-tetrahydro-pyran-2-yl) ester 5-methyl ester

Conditions
ConditionsYield
biotransformation in rat, dog, and mouse (in vivo and in vitro);
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester
39562-70-4

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid ethyl methyl ester

2,6-Dimethyl-4-(3-nitro-phenyl)-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester; compound with nitric acid

2,6-Dimethyl-4-(3-nitro-phenyl)-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester; compound with nitric acid

Conditions
ConditionsYield
With nitric acid for 4h; Heating;

39562-70-4Relevant articles and documents

Facile synthesis of 1,4-dihydropyridine monocarboxylic acids and unsymmetric dicarboxylates via quaternary ammonium salts of 2-aminoethyl 1,4-dihydropyridine-3,5-dicarboxylates

Kinugawa, Masahiko,Ogasa, Takehiro

, p. 3321 - 3331 (1997)

Useful 1,4-dihydropyridine unsymmetric dicarboxylates [nitrendipine (1), nicardipine (2)] and monocarboxylic acid 4 were prepared from unsymmetric 2-aminoethyl methyl 1,4-dihydropyridine-3,5-dicarboxylates 2 and 3 via their corresponding quaternary ammonium salts 5-9.

METHODS FOR TREATING CHRONIC FATIGUE SYNDROME AND MYALGIC ENCEPHALOMYELITIS

-

, (2021/03/13)

In one aspect the invention relates to a method of treatment selected from the group consisting of: (a) treating a symptom such as pain in a subject identified or diagnosed as having Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS); (b) treating a symptom such as pain in a subject having dysfunctional TRPM3 ion channel activity; (c) restoring NK cell function in a subject having dysfunctional TRPM3 ion channel activity; and (d) restoring calcium homeostasis in a subject having dysfunctional TRPM3 ion channel activity. The method comprises the step of administering to the subject a therapeutically effective amount of at least one therapeutic compound selected from the group consisting of: (i) an opioid receptor antagonist; (ii) an opioid antagonist; and (iii) a therapeutic compound that restores TRPM3 ion channel activity. In some embodiments the therapeutic compound is naltrexone hydrochloride.

Preparation method of nitrendipine

-

Paragraph 0051-0071, (2020/05/14)

The invention belongs to the technical field of medicines, and particularly relates to a preparation method of nitrendipine, which comprises the following steps: adding (E)-2-(3-nitrobenzylidene)-3-oxobutyrate and methyl 3-aminocrotonate into a first solvent, and carrying out a reflux reaction at a first temperature to obtain a first reaction solution; adding acetic anhydride into the first reaction solution at a second temperature to react to obtain a second reaction solution; carrying out a stirring reaction on the second reaction solution at a third temperature, and filtering to obtain a crude product of nitrendipine; and recrystallizing the crude product of nitrendipine to obtain nitrendipine. The invention provides a preparation method of nitrendipine, and aims to effectively controldimethyl ester impurities and diethyl ester impurities, improve the yield and shorten the reaction time so as to improve the productivity.

Preparation method of nitrendipine

-

Paragraph 0042-0058, (2019/05/22)

The invention belongs to the field of drug synthesis, and particularly relates to a preparation method of nitrendipine. The preparation method is characterized by including following steps: (1), allowing 3-nitrobenzylidene ethyl acetoacetate intermediate and 3-aminomethyl crotonate according to a molar ratio of 1:1-1.1 to react at 70-75 DEG C in advance; (2), adding concentrated hydrochloric acidinto a reaction system of the step (1), and allowing reaction at 70-75 DEG C after adding is completed, wherein adding amount of the concentrated hydrochloric acid is 10-15% of molar weight of the 3-nitrobenzylidene ethyl acetoacetate intermediate; (3), cooling to 15-20 DEG C after reaction in the step (2) is completed, continuing reaction, and performing solid-liquid separation and recrystallization to obtain nitrendipine. Through process control, content of ester exchange impurities can be lowered effectively, and product yield can be increased.

Based on the three-step synthesis process of preparation of the nitrendipine (by machine translation)

-

Paragraph 0020; 0025; 0031-0032; 0035-0036; 0041-0042, (2019/02/04)

The invention discloses a method based on three-step preparation of the nitrendipine synthesis process, comprising the following steps: S1 ammoniation reaction: liquid ammonia with methyl acetoacetate reflect the generated β - amino-crotonic acid methyl ester; S2 condensation reaction: will be m formaldehyde and acetyl ethyl acetate in the catalyst piperidine and glacial acetic acid under the action of the condensation reaction to obtain the pure 2 - (3 - nitryl asia phenmethyl) - acetyl ethyl acetate; S3 ring-closure reaction: the β - amino-crotonic acid methyl ester with 2 - (3 - nitryl asia phenmethyl) - acetyl ethyl acetate in the catalyst diisopropyl ethylamine/glacial acetic acid under the action of the Michael reaction, then molecule in cyclization to obtain nitrendipine; S4 refining, the invention - nitrobenzaldehyde between (SM1), acetyl ethyl acetate (SM2) and methyl acetoacetate (SM3) as the starting raw material preparation, heating the ring, three-step reaction qualified products can be obtained nitrendipine, not containing special reaction conditions. (by machine translation)

Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 1,4-dihydropyridines as calcium channel blockers

El-Moselhy, Tarek Fathy,Sidhom, Peter Ayoub,Esmat, Eman Ahmed,El-Mahdy, Nageh Ahmed

, p. 893 - 903 (2018/10/31)

Resurgence to target L-type voltage-dependent calcium channels has been applied by the synthesis of two series of nifedipine analogues where the ortho- or a meta-nitrophenyl ring is retained. A pre-synthetic molecular docking study with a receptor model followed by molecular alignment has been performed on 47 compounds to predict the most active member. The IC50 values revealed that some of the compounds are similar to or more active than nifedipine. Substitution of groups at the 3- and 5-positions of the dihydropyridine (DHP) ring gave 3k, which is more active than nifedipine. Our valid three-dimensional quantitative structure–activity relationship (3D-QSAR) model prefigures the influence of lipophilicity, bulkiness and chelating effects of the C3 and C5 substituents. Bulky groups interfere with ring-to-ring hydrophobic interaction with tyrosine (Tyr)4311 and limit the efficiency of increasing the length of the hydrocarbon chain of esters at the 3- and 5-positions of the DHP ring as an approach to increasing the activity. The presence of a chelating substituent on the phenyl ring at the 4-position of the DHP ring ensures strong binding to the receptor and hence stabilization of the closed-channel conformation. The validation of 3D-QSAR model indicated its proficiency in predicting activity of newly compounds belonging to the same chemical class.

An efficient and recyclable 3D printed α-Al2O3 catalyst for the multicomponent assembly of bioactive heterocycles

Azuaje, Jhonny,Tubío, Carmen R.,Escalante, Luz,Gómez, Mónica,Guitián, Francisco,Coelho, Alberto,Caama?o, Olga,Gil, Alvaro,Sotelo, Eddy

, p. 203 - 210 (2016/12/09)

A catalytic methodology is reported that enables the efficient, operationally simple and environmentally friendly synthesis of diverse 1,4-dihydropyridines and 3,4-dihydropyrimidin-2(1H)-ones, including some relevant drugs and pharmacologically active derivatives. This strategy is based on the use of a 3D printed Al2O3 woodpile material that was sintered to generate a rigid structure with controlled porosity and noteworthy catalytic performance. The 3D printed Al2O3 catalyst exhibits remarkable efficacy as a Lewis acid in Biginelli and Hantzsch reactions and it can be recovered and reused ten times without any decrease in the activity. Remarkable E factors, excellent recyclability and scalability, broad substrate scope, short reaction times, excellent yields, solvent-free conditions and easy isolation procedures are key features of this methodology.

First Report About the Use of Micellar Keggin Heteropolyacids as Catalysts in the Green Multicomponent Synthesis of Nifedipine Derivatives

Palermo, Valeria,Sathicq, ángel G.,Constantieux, Thierry,Rodríguez, Jean,Vázquez, Patricia G.,Romanelli, Gustavo P.

, p. 1634 - 1647 (2016/08/30)

Abstract: Micellar Keggin heteropolyacid catalysts were prepared using hexadecyltrimethylammonium bromide (cetyltrimethylammonium bromide—CTAB), 1-hexadecyl-pyridinium chloride, and Keggin heteropolyacids H3PMo12O40 and H4PMo11VO40 as precursors. Four catalysts were prepared (PMo12C16, PMo11VC16, PMo12C16Py, and PMo11VC16Py) and characterized by 31P NMR, FT-IR, XRD, SEM analysis and textural properties (SBET). The acidic characteristics of the catalysts were determined by potentiometric titration with n-butylamine. A series of bioactive 1,4-dihydropyridine derivatives such as nifedipine and nemadipine B were synthesized using these new materials, in a one-pot procedure in ethanol. This methodology requires a reaction time of 8?h, and a temperature of 78?°C to obtain good to excellent yields of 1,4-dihydropyridine derivatives. The micellar Keggin catalysts are insoluble in polar media, which allows easy removal of the reaction products without affecting their catalytic activity. The leaching test showed that they have an excellent stability and can be used five times as heterogeneous catalysts without appreciable loss of the catalytic activity. Using the same material, unsymmetrical 1,4-dihydropyridines such as nitrendipine can be obtained through a sequence of steps in very good yield (78?%). Graphical Abstract: [Figure not available: see fulltext.]

Synthesis and antihypertensive activity evaluation in spontaneously hypertensive rats of nitrendipine analogues

Zhou, Kai,Wang, Xiao-Meng,Zhao, Yi-Zhi,Cao, Yong-Xiao,Fu, Qiang,Zhang, San-Qi

, p. 1325 - 1330 (2012/06/04)

The antihypertensive activity of nitrendipine analogues can be improved by properly lengthening its alkyl chain in 3- or 5-position. Nitrendipine and its seven analogues were synthesized, and their antihypertensive activities in spontaneously hypertensive rats (SHR) were evaluated by ig administration. It was found that 5-n-heptyl 3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4- dihydropyridine- 3,5-dicarboxylate [(±)-5] exhibited the strongest antihypertensive effect amongst eight compounds. (?)-5-nheptyl 3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate [(+)-5] was also prepared. Antihypertensive activities of (±)-5 and (?)-5 in SHR were compared. The results showed that (±)-5 and (?)-5 had a higher potency than nitrendipine, and (+)-isomer was 1.79-fold the raceme at a dose of 2 mg/kg. Springer Science+Business Media, LLC 2010.

Catalytic effect of nanosized metal oxides on the Hantzsch reaction

Fedorova,Koryakova,Valova,Ovchinnikova,Titova,Rusinov,Charushin

experimental part, p. 566 - 572 (2011/01/07)

The effect of nanosized copper and aluminum oxides, which have a higher sorption capacity than that of bulk samples, on the Hantzsch reaction was studied. The adsorption of starting benzaldehydes and ethyl acetoacetate on the surface of copper and aluminum nanooxides resulted in the activation of these molecules and accelerated the Hantzsch reaction. In addition, considerable activation of ammonia and intermediates (chalcone and enamine) on the surface of aluminum nanooxide facilitated an increase in the rate and selectivity of the process. The experimental results were used to develop a one-pot method for the preparation of nifedipine and nitrendipine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 39562-70-4